Antibody-targeted paclitaxel loaded nanoparticles for the treatment of CD20+ B-cell lymphoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibody-targeted paclitaxel loaded nanoparticles for the treatment of CD20+ B-cell lymphoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-04-05
DOI
10.1038/srep45682
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of Maintenance Therapy after High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation in Aggressive Lymphomas: A Systematic Review
- (2016) Josephine A. Taverna et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Antibody Drug Conjugates (ADCs): Changing the Treatment Landscape of Lymphoma
- (2016) Deepa Jagadeesh et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- A randomized, controlled phase III trial ofnab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma
- (2015) E. M. Hersh et al. ANNALS OF ONCOLOGY
- Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: Is the crosslinked version more advantageous?
- (2014) Chunlei Li et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer
- (2013) N. Awasthi et al. CARCINOGENESIS
- Phase III Randomized Study of Rituximab/Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) Compared With Iodine-131 Tositumomab/BEAM With Autologous Hematopoietic Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma: Results From the BMT CTN 0401 Trial
- (2013) Julie M. Vose et al. JOURNAL OF CLINICAL ONCOLOGY
- Brentuximab vedotin in Hodgkin's lymphoma
- (2012) Barbara Pro et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study
- (2012) Barbara Pro et al. JOURNAL OF CLINICAL ONCOLOGY
- Non-Hodgkin lymphoma
- (2012) Kate R Shankland et al. LANCET
- Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphoma
- (2011) R. Griffiths et al. BLOOD
- Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
- (2011) Twan Lammers et al. JOURNAL OF CONTROLLED RELEASE
- Utilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer
- (2011) Daniel C. Julien et al. mAbs
- Human serum albumin: From bench to bedside
- (2011) Gabriella Fanali et al. MOLECULAR ASPECTS OF MEDICINE
- What Happened to Anti-CD33 Therapy for Acute Myeloid Leukemia?
- (2011) Joseph G. Jurcic Current Hematologic Malignancy Reports
- The Role of Basal Insulin and Glucagon-Like Peptide-1 Agonists in the Therapeutic Management of Type 2 Diabetes—A Comprehensive Review
- (2010) Satish K. Garg Diabetes Technology & Therapeutics
- Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-α in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 2 or 3
- (2010) David R. Nelson et al. GASTROENTEROLOGY
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
- (2010) M Hallek et al. LANCET
- Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study
- (2008) G. Salles et al. BLOOD
- Application of Nanotechnology in Cancer Therapy and Imaging
- (2008) X. Wang et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Phase III Study of R-CVP Compared With Cyclophosphamide, Vincristine, and Prednisone Alone in Patients With Previously Untreated Advanced Follicular Lymphoma
- (2008) Robert Marcus et al. JOURNAL OF CLINICAL ONCOLOGY
- Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma
- (2008) Annina Herrmann et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation